Insight

Sabine D. Brookman-May: Time to Treat Physical Activity as a Systemic Anticancer Therapy

Sabine Brookman-May/X

Aug 11, 2025, 17:15

Sabine D. Brookman-May: Time to Treat Physical Activity as a Systemic Anticancer Therapy

Sabine D. Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences, shared a post on X about a paper she co-authored with colleagues published in European Urology:

“Words of Wisdom just published in European Urology:

Exercise post chemo cuts recurrence by 28%/mortality by 37% in the CHALLENGE colon cancer trial.
Time to treat physical activity as a systemic anticancer therapy. Exercisumab also in urologic oncology and exercise oncology.”

Title: Re: Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

Authors: Sabine D. Brookman-May, Shimon Kempin, Benazir Enzinger

You can read the Full Article on European Urology.

Sabine D. Brookman-May: Time to Treat Physical Activity as a Systemic Anticancer Therapy

More posts featuring Sabine D. Brookman-May.

Benazir Enzinger cancer european urology Exercise Oncology Exercisumab OncoDaily Oncology Physical Activity Sabine D. Brookman-May Shimon Kempin urologic oncology

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC